Part of the Internal Medicine Commons

Works by C.B. Andersen in Internal Medicine

2013

Lung Transplant Recipients Suspected of Antibody Mediated Rejection Treated with Plasmapheresis Have a Poor Prognosis, C.G. Dirks, M.B. Damholt, W. Szpirt, H. Bruunsgaard, C.B. Andersen, J. Carlsen, M. Perch, L. Mared, M. Iversen
Maura Iversen

Time after Lung Transplantation Influence the Correlation between Acute Rejection and Frequency of Regulatory T Cells in Transbronchial Lung Biopsies, D. Krustrup, M. Iversen, C.B. Andersen
Maura Iversen

2012

526 Chronic Allograft Dysfunction after Lung Transplantation. A Comparison of RAS vs. BOS, C.H. Møller, M. Jørgensen, M. Perch, C.B. Andersen, J. Carlsen, D.A. Steinbrüchel, M. Iversen
Maura Iversen

2011

Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation, M. Kohno, M. Kohno, M. Perch, E. Andersen, J. Carlsen, C.B. Andersen, M. Iversen
Maura Iversen

2008

85: Diffuse Alveolar Damage (DAD) after Lung Transplantation: Early Pulmonary Injury Was Not Associated with the Development of Bronchiolitis Obliterans, C.M. Burton, M. Iversen, J. Carlsen, T. Scheike, C.B. Andersen
Maura Iversen

2005

A comparison between antithymocyte globulin and dacluzimab induction therapy for lung transplantation. A retrospective analysis of the frequency of acute cellular rejection in 270 patients, C.M. Burton, A.S. Jensen, S. Boesgaard, N. Milman, H. Arendrup, K. Eliasen, C.B. Andersen, M. Iversen, J. Carlsen
Maura Iversen